These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Objective assessment of heparin requirements for hemodialysis in humans. Ireland H, Lane DA, Curtis JR. J Lab Clin Med; 1984 Apr; 103(4):643-52. PubMed ID: 6230409 [Abstract] [Full Text] [Related]
5. A low molecular weight heparin ("fragmin") for routine hemodialysis: a crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparin. Anastassiades E, Lane DA, Ireland H, Flynn A, Curtis JR. Clin Nephrol; 1989 Dec; 32(6):290-6. PubMed ID: 2558829 [Abstract] [Full Text] [Related]
6. A low molecular heparin fraction as an anticoagulant during hemodialysis. Ljungberg B. Clin Nephrol; 1985 Jul; 24(1):15-20. PubMed ID: 4017295 [Abstract] [Full Text] [Related]
8. Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation. Ireland HA, Boisclair MD, Lane DA, Thompson E, Curtis JR. Clin Nephrol; 1991 Jan; 35(1):26-33. PubMed ID: 1826095 [Abstract] [Full Text] [Related]
9. Low molecular weight heparin and haemodialysis: neutralization by protaminchloride. Andrassy K. Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S39-43. PubMed ID: 8180328 [Abstract] [Full Text] [Related]
10. Dose finding study of a low molecular weight heparin, Innohep, in haemodialysis. Ryan KE, Lane DA, Flynn A, Shepperd J, Ireland HA, Curtis JR. Thromb Haemost; 1991 Sep 02; 66(3):277-82. PubMed ID: 1745997 [Abstract] [Full Text] [Related]
12. Fibrinolytic and anticoagulant activity after a single subcutaneous administration of a low dose of heparin or a low molecular weight heparin-dihydroergotamine combination. Grimaudo V, Omri A, Kruithof EK, Hauert J, Bachmann F. Thromb Haemost; 1988 Jun 16; 59(3):388-91. PubMed ID: 2847348 [Abstract] [Full Text] [Related]
13. A single dose of a low molecular weight heparin fragment for anticoagulation during hemodialysis. Ljungberg B, Blombäck M, Johnsson H, Lins LE. Clin Nephrol; 1987 Jan 16; 27(1):31-5. PubMed ID: 3815906 [Abstract] [Full Text] [Related]
15. The effects of three different heparin regimes on heparin concentrations in plasma and fibrin formation in dialyzers. Gunnarsson B, Asaba H, Dawidson S, Wilhelmsson S, Bergström J. Clin Nephrol; 1981 Mar 16; 15(3):135-42. PubMed ID: 7273488 [Abstract] [Full Text] [Related]
16. A comparison between low molecular weight heparin (KABI 2165) and standard heparin in the intravenous treatment of deep venous thrombosis. Bratt G, Törnebohm E, Granqvist S, Aberg W, Lockner D. Thromb Haemost; 1985 Dec 17; 54(4):813-7. PubMed ID: 3911482 [Abstract] [Full Text] [Related]
18. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo. Eichinger S, Wolz M, Nieszpaur-Los M, Schneider B, Lechner K, Eichler HG, Kyrle PA. Thromb Haemost; 1994 Dec 17; 72(6):831-5. PubMed ID: 7740450 [Abstract] [Full Text] [Related]
19. Central venous catheter sampling of low molecular heparin levels: an approach to increasing result reliability. Bauman ME, Belletrutti M, Bauman ML, Massicotte MP. Pediatr Crit Care Med; 2012 Jan 17; 13(1):1-5. PubMed ID: 21317677 [Abstract] [Full Text] [Related]